Skip to main content
logo
Arthur J. Gallagher & Co. (AJG)
NYSE: AJG · Real-Time Price · USD
284.17
-3.08 (-1.07%)
Aug 1, 2025, 4:00 PM - Market closed

CTI BioPharma Revenue

Arthur J. Gallagher & Co. had revenue of $3.22B in the quarter ending June 30, 2025, with 22.12% growth. This brings the company's revenue in the last twelve months to $11.84B, up 14.01% year-over-year. In the year 2024, Arthur J. Gallagher & Co. had annual revenue of $10.93B with 14.31% growth.

Revenue (ttm)
$11.84B
Revenue Growth
+14.01%
P/S Ratio
5.88
Revenue / Employee
$211,491
Employees
56,000
Market Cap
72.85B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.93B1.37B14.31%
Dec 31, 20239.56B1.29B15.59%
Dec 31, 20228.27B296.20M3.71%
Dec 31, 20217.97B1.19B17.58%
Dec 31, 20206.78B-112.40M-1.63%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Berkshire Hathaway371.29B
JPMorgan Chase & Co.163.65B
Bank of America98.46B
Wells Fargo & Company77.62B
Morgan Stanley65.61B
American Express Company63.44B
HSBC Holdings56.21B
The Goldman Sachs Group54.79B
Revenue Rankings

AJG News

More News